Stem Cells: The Mayo Clinic

Total Score People Score Events Score
41 35 19
Date Event Presentation Speakers
March 2, 2014 Alzheimer’s Disease – From Fundamental Insights to Light at the End of the Translational Tunnel (Q8) Phenotypic and Genotypic Complexity of AD and PD (Joint) Registered attendees can view abstracts starting on 02/02/2014 Dennis Dickson
May 31, 2013 ASCO Annual Meeting 2013 What's New and Improved in the Care of Children with Rhabdomyosarcoma? Carola A. S. Arndt
Responding to Common Concerns of Patients with Cancer: What's New—In a Nutshell—From Research to Therapeutic Strategies Charles L. Loprinzi
Uncommon Lymphoproliferative Disorders (C01) Angela Dispenzieri
Rationally Combining Targeted and Pathway-Specific Agents Edith A Perez
Special Session David P Steensma
Education Sessions Gloria M. Petersen
April 6, 2013 AACR Annual Meetings Targeting Lymphoid Malignancies: Working from the Outside In Co-Chairpersons: John P. Leonard, Weill Cornell Medical Center, New York, NY, and John C. Byrd, The Ohio State University Comprehensive Cancer Center, Columbus, OH James R. Cerhan
Endocrine Resistance in Breast Cancer Chairperson: Nancy E. Davidson, University of Pittsburgh Cancer Institute, Pittsburgh, PA Matthew P . Goetz
DNA Damage Response: What Do We Know Now and What Will We Learn Next? Chairperson: Junjie Chen, The University of Texas MD Anderson Cancer Center, Houston, TX Junjie Chen
Genetic Epidemiology of Pancreatic Cancer Gloria M. Petersen, Mayo Clinic College of Medicine, Rochester, MN Gloria M. Petersen
February 3, 2013 New Frontiers in Neurodegenerative Disease Research (J8) Non-Coding Repeat Expansions in C9ORF72 as a Novel Cause of Frontotemporal Dementia and Amyotrophic Lateral Sclerosis Rosa Rademakers
Molecular Mechanisms of Neuronal Vulnerability Rosa Rademakers
August 14, 2011 Gastrointestinal Tract XIV: Stem Cells, Adaptation, Inflammation and Cancer Session 3 | Stem Cells and Neoplasia in the Digestive System John J. Lynch
March 27, 2011 Congress on Steroid Research Molecular basis of de novo and acquired aromatase inhibitor resistance S Cheng
February 17, 2011 15th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma Promising New Drugs in Clinical Trials in Myeloma Keith Stewart
CON Keith Stewart
How I Treat Myelofibrosis If No Clinical Trial Is Available Ruben A Mesa
Multiple Myeloma Keith Stewart
Chronic Myeloid Leukemia | Myeloproliferative Neoplasms Ruben A Mesa
January 12, 2011 Type 2 Diabetes, Insulin Resistance and Metabolic Dysfunction (J1) Insulin Resistance, Mitochondrial Dysfunction and Lipotoxicity in Humans | Muscle Mitochondrial Dysfunction and Muscle Insulin Resistance in Diabetes Sreekumaran Nair
January 12, 2011 Obesity (J2) Diabetes (J1) | Muscle Mitochondrial Dysfunction and Muscle Insulin Resistance in Diabetes Sreekumaran Nair
October 21, 2010 21st Century Treatment of Heart Failure Session V: Update on the Medical and Surgical Management of Ischemic Cardiomyopathy Soon J Park
January 22, 2010 2010 Gastrointestinal Cancers Symposium Oral Abstract Session: Cancers of the Esophagus and Stomach Michael G Haddock
FISH Analysis to Diagnose Biliary Cancers Gregory J. Gores
Minimally Invasive Surgical Approaches to Colorectal Cancer Heidi Nelson
New Screening Models: Blood, Stool, Capsule Endoscopy David A. Ahlquist
Case Presentation 2: Metastatic But Potentially Curable Axel Grothey
Case Presentation 3: Stage Iva After Primary Surgery for Synchronous Liver Metastases- Previously Untreated Axel Grothey
September 11, 2009 Sixth Annual Symposium on Controversies and Clinical Challenges In Lymphoma, Myeloma, and Leukemia Clinical Challenges in TCLs Barbara Pro
Clinical Challenges in Treating Patients With MPDs Ruben A Mesa
Timing of Transplant Shaji Kumar
Complete Response and Clinical Benefit P. Leif Bergsagel
Cytogenetics, Prognosis, and New Therapies in MM Keith Stewart
Management of Relapsed Myeloma Shaji Kumar
Keynote Presentation: Integrated Therapies: A View From the Bench Rafael Fonseca
Clinical Challenges in CML Resistant to TKIs Ruben A Mesa
February 28, 2009 PEDIATRIC ORTHOPAEDIC SOCIETY OF NORTH AMERICA Guided Growth Anthony Stans
December 11, 2008 SAN ANTONIO BREAST CANCER SYMPOSIUM Risk assessment and risk reduction strategies: Overview Lynn C Hartmann
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Developmental Therapeutic Approaches to Triple-Negative Breast Cancer Edith A Perez
developmental therapeutics-- Developmental Therapeutic Approaches to Triple-Negative Breast Cancer Edith A Perez
gastrointestinal (noncolorectal) cancer-- Multimodality Treatment of Bile Duct Tumors (M14) Steven R. Alberts
leukemia, myelodysplasia, and transplantation-- Myeloproliferative Disorders at the Cutting Edge Ayalew Tefferi
lymphoma and plasma cell disorders-- Initial Therapy for Multiple Myeloma: Considerations for an Integrated Risk- Adapted Approach S. Vincent Rajkumar
meet the professor sessions-- Multimodality Treatment of Bile Duct Tumors (M14) Steven R. Alberts
December 1, 2007 47TH American Socieity of Cell Biology Symposium II:Architecture of Signaling Systems Marks L Richard
Stochasticity and Cell Fate Marks L Richard
Advances in Bone Cell Molecular Biology: Epigenetic Control Jennifer Westendorf
Dynamics of Rafts, Stabilized Rafts, and Other Non-Raft Domains of Mark A McNiven
November 4, 2007 AACR Centennial Conference: Translational Cancer Medicine Concurrent Session 5: Advances in Cancer Therapeutics Alex A Adjei
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.